According to a new report from Intel Market Research, the global Encorafenib market was valued at USD 320 million in 2024 and is projected to reach USD 620 million by 2034, growing at a steady CAGR of 6.8% during the forecast period (2025-2034). This expansion reflects the growing clinical adoption of BRAF-targeted therapies for metastatic melanoma...
English
Indonesia
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Greek